Coverage dated July 27, 2026 to July 29, 2026
Compounded GLP-1 drugs creating concern among doctors and FDA
Headline from KXAN Austin
They're often cheaper and easier to get than Ozempic, but doctors say compounded GLP-1 drugs come with serious risks.
KXAN Austin's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Reports & sources
10 articles, oldest first.
KXAN Austin
Compounded GLP-1 drugs creating concern among doctors and FDA ↗ (opens KXAN Austin)Published
KXAN Austin's feed description
They're often cheaper and easier to get than Ozempic, but doctors say compounded GLP-1 drugs come with serious risks.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
